Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial

BACKGROUND: Magnesium sulphate is a neuroprotective agent that might improve outcome after aneurysmal subarachnoid haemorrhage by reducing the occurrence or improving the outcome of delayed cerebral ischaemia. We did a trial to test whether magnesium therapy improves outcome after aneurysmal subarac...

Descripción completa

Detalles Bibliográficos
Autores principales: Mees, Sanne M Dorhout, Algra, Ale, Vandertop, W Peter, van Kooten, Fop, Kuijsten, Hans AJM, Boiten, Jelis, van Oostenbrugge, Robert J, Salman, Rustam Al-Shahi, Lavados, Pablo M, Rinkel, Gabriel JE, van den Bergh, Walter M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Publishing Group 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391717/
https://www.ncbi.nlm.nih.gov/pubmed/22633825
http://dx.doi.org/10.1016/S0140-6736(12)60724-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391717/
https://www.ncbi.nlm.nih.gov/pubmed/22633825
http://dx.doi.org/10.1016/S0140-6736(12)60724-7

Ejemplares similares